Last updated: 2026-09-09 04:30:01. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Tandem Diabetes Care, Inc. (TNDM) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $19.88, with a market capitalization of $1.38B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $11.46 to $29.65. This page covers its latest market performance, valuation, price trends and company information.
$1.38B | |
$19.51 | |
$345.60 | |
$2.14 | |
$19.90 | |
1.48M | |
1.96M | |
-- | |
$29.65 | |
$11.46 | |
-- | |
-- |
Tandem Diabetes Care, Inc. (TNDM) last closed at $19.90 as of 2026-09-08 23:31:00, unchanged from the previous close of $19.90.
During the latest regular trading session, TNDM traded between $2.14 and $345.60, with a volume of 1.48M shares. The closing price was near the lower end and near the middle of its 52-week range.
Over the past seven days, Tandem Diabetes Care, Inc. (TNDM) moved from $21.40 to $19.88, representing a decline of 7.10% ($1.52).
The stock traded between $19.49 and $22.30 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.23 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 46.3%
TNDM is currently trading at $19.88, placing it 46.3% of the way from its 52-week low of $11.46 to its 52-week high of $29.65. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 2500 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Tandem Diabetes Care, Inc. (TNDM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.